NCT07472517 2026-03-31
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy
Boehringer Ingelheim
Phase 3 Not yet recruiting
Boehringer Ingelheim
Peking University Cancer Hospital & Institute
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano